Really cool news out of the UK today: experts there claim they are on the verge of perfecting a tiny mobile phone microchip to diagnose medical conditions on the spot. According to execs at Orla Protein Technologies and Tokyo-based Japan Radio Company, the diminutive device will read swabs and blood tests and slot into a [...]
More positive news for bio-tech in New England!
Even as the economy shrinks and VC money gets harder to come by, innovation is still be nurtured and rewarded for local life sciences companies. According to Mass High Tech today, Proteon Therapeutics, Inc. has completed a second closing of its Series B equity financing, raising an additional [...]
The 2009 Bio International Convention, which took place in Atlanta last week, was host to a number of educational sessions around biotech innovations, including one that highlighted the need for drawing a closer connection between research and clinical care. As FierceBiotech IT reported, EHRs were at the center of a discussion on “Transforming the Research [...]
Late last week, Massachusetts General Hospital (MGH) announced the development of software that could allow diagnosis of early Alzheimer’s disease. The software program, developed at the Martinos Center for Biomedical Imaging at MGH, differentiates between patients with mild cognitive impairment (a lesser form of dementia that precedes the development of Alzheimer’s by several years) from [...]
One of the latest technologies out of MIT to draw attention popped up last week in EDN, of all places. We read EDN regularly (the pub is important to many of our clients in other practices, after all), but it’s not often we find innovations in the life sciences inside. But this one is truly [...]
The company, Eyenovations, is developing contact lenses that can administer drugs directly to the eye for a period of a month or more. This approach would be an alternative to sometimes difficult-to-follow eye medicine regimens which can require precise and specifically-timed dosage. While the company’s first focus is developing a contact lens medication solution for [...]
Even as jobs and economic growth slow nationally, a report from the Milken Institute ranks Boston first in sustaining and building value in the life science industry. Followed by Philadelphia and San Francisco, Boston topped the list of regions that cultivate and support life science companies, universities, hospitals, tech spin-offs and start-ups. The study looked [...]
And they’re off! In follow-up to Knome, Inc.’s April announcement that it would auction off a whole genome sequencing, analysis, and interpretation service of an individual genome (http://www.knome.com/about/news/20090423.html), the Cambridge, MA-based genomics services provider has now announced it is launching a new genomic analysis offering that comes to about $1 per gene:
http://www.masshightech.com/stories/2009/05/18/daily5-Knome-rolls-out-genome-sequencing-for-1-per-gene.html
These are two notable “firsts” within a [...]
Last week, FierceBiotech came out with its fourth annual Top 5 economic development report, and the results are promising for one New England state, which has been named to the list for the second year in a row – Massachusetts. 2009 also marks the exit of perennial trendsetter California, a repeat appearance for New York, [...]
This past week, The Boston Globe uncovered a great story about a New England mother’s efforts to help find a cure for Duchenne Muscular Dystrophy (DMD) in an attempt to save the life of her afflicted son. Also highlighted in the article is a tiny local startup, which has developed a machine that can test thousands [...]